ScientificMulti-institute Research on Nasal Delivery of Tiba’s RNABL™ Nanoparticles Published in SCIENCE IMMUNOLOGY
In a study published in Science Immunology, University of Minnesota researchers in collaboration with colleagues at Tiba Biotech and Emory University, demonstrated that nasal delivery of Tiba's RNABL vaccine induced adaptive immune responses in the respiratory tracts of mice.